The Norwegian Health Investor Network is proud to have established an Advisory Board made up of key stakeholders from the Norwegian investor community.
The Norwegian Health Investor Network (NHIN) aims to engage the investor community and increase the amount of funding for early stage companies focused on health.
But how do we actually do that!?
We attract investors by showcasing relevant investment opportunities (companies), and presenting them via a platform which people trust. We have secured a strong flow of opportunities through established relationships with key accelerators, TTO’s and clusters who are natural attractors for these companies.
Ok, we’ve secured the deal-flow but how do we build that trust!?
We establish an advisory board made up of seasoned investors from different investment backgrounds and regions to lend us their knowledge and a touch of their credibility, to ensure that the direction, events and information being focused on and shared is inline with what community members expect.
So that’s what we did… please meet our guiding lights...
Masha has extensive experience within the field of Healthcare, both from the scientific and the financial standpoints. She has been involved with a number of companies in the sector, developing strategy and value proposition.
Before joining corporate finance with Morgan Stanley in London, she was awarded a Rhodes scholarship and completed her D.Phil. in Genetics at Oxford University (Department of Biochemistry). She has made several investments with startups in the Medtech and Biotech sector. Her strengths lie in combining her understanding of health technology with a commercial outlook (science, trends, competition, valuation).
That’s the bio. To frame this more tangibly, Masha is purely and simply a success catalyst for early stage companies. Her involvement means an immediate stamp of ‘high potential’ for those companies fortunate enough to secure her interest. Masha implants ambition, practical, hands-on strategy and advice from initial company setup and governance, to structuring and spearheading a company exit, and everything in between. She has a trusted network of investors and is not afraid to get her hands dirty to understand the company, technology, market potential and ask the hard questions of the people behind it to determine the realistic likelihood of success. This level of scrutiny and understanding leads Masha and her family office PACCS Invest, which she runs with her ex-investment banker husband Dag Stromme (equally impressive), to take the lead on investments more often than not.
In short, Masha is an unbelievable asset for the NHIN and we could not think of anyone better to lead our path to success.
Ann-Tove Kongsnes is an Investment Director at Investinor AS, heading the investment team for health investment (pharma/biotech, med tech and digital health investments). Kongsnes has over her career gained extensive experience form investments, development, M&A, IPO’s and exits of technology companies.
Prior to this, she worked for 7 years with international marketing, and was formerly a Director of Marketing and Operations. Kongsnes has extensive board experience, and currently serves on the boards of 7 of Investinor’s portfolio companies, in addition to 4 Chair/member seats in Nomination Committees. She holds an MSc in Economics and Business Administration from HIB and took the Advanced Program in Corporate Finance at NHH.
Practically, Ann-Tove brings a powerhouse of brand credibility with her from Investinor and a wealth of experience in governance and what companies need to do to be deemed ‘investable’.
We are extremely happy to have Ann-Tove around to share her vast experience and ask us the hard questions on behalf of investors to ensure we deliver value to all stakeholders.
Kristin Odfjell is a tech investor through Planet 9 Venture, the tech investment arm of Farvatn. The focus of Planet 9 Venture is to support promising technology companies which have potential to become global leaders in the fields of Life Science and Ocean verticals.
Planet 9 Venture has specific ambitions to equally support male and female founders. We are therefore associated with Astia Angel Network which is levelling the playing field for women entrepreneurs by providing access to capital and networks for the companies they lead.
Kristin has more than 20 years of experience from life science working as Clinical Research Associate (CRA) in Norway. In this capacity her most recent activity has been clinical research for Obsessive Compulsive Disorder projects within Haukeland University Hospital. She has also managed projects for Pharmacia, Pfizer and Link Medical Research.
The Odfjell name is synonymous with ‘exciting investment’. Kristin and her husband Johan, manage their family office and are prolific within the startup and investment ecosystems within Norway and further abroad, having spent significant time in Silicon Valley assessing investments, absorbing knowledge and developing a strong network which they then brought back to Norway.
Kristin is a highly respected and sought after investor within many domains, including the health sector. She has a vast network of investors who watch her activities and often follow her lead.
We are very proud to be associated with the Kristin Odfjell brand and to be guided by the valuable insights Kristin so readily shares with us - always delivered with a touch of positivity and more than a dash of charm!
Haakon is a senior business leader, strategy expert, investor, and fund manager with more than 25 years of international experience. Haakon runs the Trondheim office of Norway’s longest running health Cluster (Norway Health Tech).
Haakon is also currently a board member of the Norwegian Business Incubator and Cluster Association (FIN), NTNU Department of Physics, and Tequity Cluster.
Haakon has previously served as CEO of the university incubator NTNU Accel, managed the pre-seed fund NTNU Preseed, and co-founded and served as CEO of the independent business strategy agency T:LAB. Haakon has previously served as non-executive director of marketing at Atmel Corp and holds a MSc in electronics from the Norwegian University of Science and Technology.
Haakon is an Angel investor and is heavily involved in the Angel ecosystem throughout Norway. Never short of a well-structured thought, his strength of network and practical business sense are a significant asset to our network and members and we’re delighted he is involved.